RT-PCR/MALDI-TOF diagnostic target performance reflects circulating SARS-CoV-2 variant diversity in New York City

Matthew M. Hernandez, Radhika Banu, Ana S. Gonzalez-Reiche, Brandon Gray, Paras Shrestha, Liyong Cao, Feng Chen, Huanzhi Shi, Ayman Hanna, Juan David Ramírez, Adriana van de Guchte, Robert Sebra, Mount Sinai PSP Study Group, Melissa R. Gitman, Michael D. Nowak, Carlos Cordon-Cardo, Ted E. Schutzbank, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Alberto E. Paniz-Mondolfi
doi: https://doi.org/10.1101/2021.12.04.21267265

Article Information

doi 
https://doi.org/10.1101/2021.12.04.21267265
History 
  • December 7, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matthew M. Hernandez1,#,
  2. Radhika Banu1,
  3. Ana S. Gonzalez-Reiche2,
  4. Brandon Gray1,
  5. Paras Shrestha1,
  6. Liyong Cao1,
  7. Feng Chen1,
  8. Huanzhi Shi1,
  9. Ayman Hanna1,
  10. Juan David Ramírez1,3,
  11. Adriana van de Guchte2,
  12. Robert Sebra2,4,5,6,
  13. Mount Sinai PSP Study Group1,2,7,
  14. Melissa R. Gitman1,
  15. Michael D. Nowak1,
  16. Carlos Cordon-Cardo1,
  17. Ted E. Schutzbank8,
  18. Viviana Simon1,7,9,10,
  19. Harm van Bakel2,4,
  20. Emilia Mia Sordillo1 and
  21. Alberto E. Paniz-Mondolfi1,#
  1. 1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  2. 2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  3. 3Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
  4. 4Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  5. 5Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  6. 6Sema4, a Mount Sinai venture, Stamford, CT 06902, USA
  7. 7Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  8. 8Senior Scientific Affairs Manager, Infectious Diseases, Agena Bioscience, San Diego, CA 92121, USA
  9. 9Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  10. 10The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  1. ↵#Corresponding authors: matthew.hernandez{at}mssm.edu, alberto.paniz-mondolfi{at}mountsinai.org
Back to top
Posted December 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
RT-PCR/MALDI-TOF diagnostic target performance reflects circulating SARS-CoV-2 variant diversity in New York City
Matthew M. Hernandez, Radhika Banu, Ana S. Gonzalez-Reiche, Brandon Gray, Paras Shrestha, Liyong Cao, Feng Chen, Huanzhi Shi, Ayman Hanna, Juan David Ramírez, Adriana van de Guchte, Robert Sebra, Mount Sinai PSP Study Group, Melissa R. Gitman, Michael D. Nowak, Carlos Cordon-Cardo, Ted E. Schutzbank, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Alberto E. Paniz-Mondolfi
medRxiv 2021.12.04.21267265; doi: https://doi.org/10.1101/2021.12.04.21267265
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area